Biohit Oyj (HEL:BIOBV)
2.330
+0.020 (0.87%)
May 18, 2026, 6:29 PM EET
Biohit Oyj Balance Sheet
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.54 | 3.75 | 3.27 | 2.12 | 1.1 |
Short-Term Investments | 1.31 | 2.96 | 3.54 | 4.11 | 4.41 |
Cash & Short-Term Investments | 4.85 | 6.71 | 6.81 | 6.23 | 5.52 |
Cash Growth | -27.71% | -1.54% | 9.43% | 12.91% | -9.28% |
Accounts Receivable | 3.25 | 2.72 | 3.66 | 2.34 | 2.26 |
Other Receivables | 0.35 | 0.49 | 0.47 | 0.41 | 0.46 |
Receivables | 3.6 | 3.21 | 4.13 | 2.75 | 2.72 |
Inventory | 0.8 | 1.03 | 0.89 | 0.92 | 0.75 |
Other Current Assets | -0 | 0 | - | - | - |
Total Current Assets | 9.25 | 10.95 | 11.83 | 9.9 | 8.99 |
Property, Plant & Equipment | 1.86 | 0.7 | 0.77 | 0.99 | 0.42 |
Long-Term Investments | 0.13 | 0.14 | 0.12 | 0.06 | 0.06 |
Other Intangible Assets | 0.64 | 0.41 | 0.18 | 0.04 | 0.14 |
Long-Term Accounts Receivable | 7.49 | 3.2 | - | - | - |
Long-Term Deferred Tax Assets | 0.37 | 0.02 | 0.02 | 0.02 | 0.01 |
Long-Term Deferred Charges | 0.07 | 0.08 | - | - | - |
Other Long-Term Assets | - | -0 | - | 0 | -0 |
Total Assets | 19.81 | 15.5 | 12.92 | 11.02 | 9.61 |
Accounts Payable | 1.04 | 0.68 | 0.47 | 0.68 | 0.58 |
Accrued Expenses | 1.37 | 1.41 | 1.69 | 1.44 | 1.27 |
Current Portion of Leases | 0.34 | 0.3 | 0.28 | 0.26 | 0.07 |
Current Income Taxes Payable | 0.84 | 0.42 | 0.37 | 0.14 | 0.18 |
Other Current Liabilities | 0.03 | 0.21 | 0.26 | 0.36 | 0.05 |
Total Current Liabilities | 3.61 | 3.02 | 3.06 | 2.86 | 2.15 |
Long-Term Debt | - | - | - | - | 0.01 |
Long-Term Leases | 1.25 | 0.28 | 0.43 | 0.69 | 0.16 |
Long-Term Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
Other Long-Term Liabilities | 0 | 0.01 | 0.01 | 0.01 | 0 |
Total Liabilities | 4.87 | 3.31 | 3.49 | 3.56 | 2.31 |
Common Stock | 2.35 | 2.35 | 2.35 | 2.35 | 2.35 |
Retained Earnings | 9.3 | 6.53 | 3.84 | 1.78 | 0.98 |
Comprehensive Income & Other | 3.29 | 3.31 | 3.24 | 3.33 | 3.97 |
Shareholders' Equity | 14.94 | 12.19 | 9.43 | 7.46 | 7.3 |
Total Liabilities & Equity | 19.81 | 15.5 | 12.92 | 11.02 | 9.61 |
Total Debt | 1.59 | 0.59 | 0.7 | 0.94 | 0.23 |
Net Cash (Debt) | 3.26 | 6.12 | 6.11 | 5.28 | 5.29 |
Net Cash Growth | -46.72% | 0.16% | 15.67% | -0.06% | -7.12% |
Net Cash Per Share | 0.21 | 0.40 | 0.40 | 0.35 | 0.35 |
Filing Date Shares Outstanding | 15.2 | 15.18 | 15.11 | 15.05 | 15.05 |
Total Common Shares Outstanding | 15.2 | 15.18 | 15.11 | 15.05 | 15.05 |
Working Capital | 5.63 | 7.93 | 8.77 | 7.04 | 6.84 |
Book Value Per Share | 0.98 | 0.80 | 0.62 | 0.50 | 0.49 |
Tangible Book Value | 14.3 | 11.78 | 9.24 | 7.42 | 7.16 |
Tangible Book Value Per Share | 0.94 | 0.78 | 0.61 | 0.49 | 0.48 |
Machinery | 1.54 | 1.39 | 1.35 | 1.78 | 1.73 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.